cannabis indica

Câncer — Próstata

termo de indexação original: Cancer - Prostate

O acervo do Cannabis Indica reúne 49 estudos científicos que tocam a condição Câncer — Próstata, publicados entre 1999 e 2024. Pela leitura automatizada, 40 (82%) foram classificados como favoráveis, 7 (14%) como inconclusivos e 2 (4%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é metanálise (26 estudos), seguido de estudo laboratorial (16). Os compostos mais presentes são Anandamida (AEA), Endocanabinoide (não especificado) e Canabinoides Sintéticos WIN-x. Aparece com frequência ao lado de Câncer, Câncer — Mama e Câncer — Cérebro.

Estudos indexados
49
Período coberto
1999–2024
Favoráveis
40 · 82%
Inconclusivos
7 · 14%
Desfavoráveis
2 · 4%
Termo original
Cancer - Prostate

O acervo em números

Tipo de estudo

Metanálise26
Estudo Laboratorial16
Estudo em Animais4
Ensaio Clínico3

Direção do resultado

Favorável40
Inconclusivo7
Desfavorável2

Por década

1990s1
2000s7
2010s18
2020s23

49 estudos

Filtrar e buscar no acervo →
  1. 2024

    The Clinical Translation of α-humulene - A Scoping Review

  2. 2023

    Anti-proliferative effect of Cannabidiol in Prostate cancer cell PC3 is mediated by apoptotic cell death, NFκB activation, increased oxidative stress, and lower reduced glutathione status

    FavorávelEstudo LaboratorialCâncer
  3. 2022

    Association between cannabis use with urological cancers: A population-based cohort study and a mendelian randomization study in the UK biobank

    FavorávelMetanáliseCâncerCâncer — BexigaCâncer — Rim
  4. 2022

    Biological effects of cannabidiol on human cancer cells: Systematic review of the literature

  5. 2022

    Cannabinoids as anticancer drugs: current status of preclinical research

  6. 2022

    Controversial Link between Cannabis and Anticancer Treatments—Where Are We and Where Are We Going? A Systematic Review of the Literature

    FavorávelMetanáliseDorCâncerAnsiedadeTetraidrocanabinol (THC)THC Farmacêutico+17
  7. 2022

    Epidemiology of Δ8THC-Related Carcinogenesis in USA: A Panel Regression and Causal Inferential Study

    DesfavorávelMetanáliseCâncer — MamaCâncer — PulmãoCâncer — CólonDelta-8-THC+16
  8. 2022

    Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 2 - categorical bivariate analysis and attributable fractions

  9. 2022

    In the weeds: a retrospective study of patient interest in and experience with cannabis at a cancer center

    FavorávelMetanáliseDorCâncerAnsiedade+14
  10. 2022

    Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review

  11. 2022

    Pilot clinical and pharmacokinetic study of Δ9-Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain

  12. 2022

    Targeting the Endocannabinoid System: From the Need for New Therapies to the Development of a Promising Strategy. What About Pancreatic Cancer?

  13. 2022

    The perceptions and beliefs of cannabis use among Canadian genitourinary cancer patients

    FavorávelMetanáliseCâncerCâncer — BexigaCâncer — Rim
  14. 2021

    Anticancer Potential of Small-Molecule Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase

  15. 2021

    Cannabidiol Treatment Results in a Common Gene Expression Response Across Aggressive Cancer Cells from Various Origins

    FavorávelEstudo LaboratorialCâncerCâncer — MamaCâncer — Cérebro+2
  16. 2021

    Caryophyllene Oxide, the Active Compound Isolated from Leaves of Hymenaea courbaril L. (Fabaceae) with Antiproliferative and Apoptotic Effects on PC-3 Androgen-Independent Prostate Cancer Cell Line

    FavorávelEstudo LaboratorialCâncer
  17. 2021

    Tea tree oil extract causes mitochondrial superoxide production and apoptosis as an anticancer agent, promoting tumor infiltrating neutrophils cytotoxic for breast cancer to induce tumor regression

    FavorávelEstudo LaboratorialCâncerEstresse OxidativoCâncer — MamaOutros Compostos Relacionados+6
  18. 2021

    Therapeutic effects of β-caryophyllene on proliferative disorders and inflammation of the gerbil prostate

    FavorávelEstudo em AnimaisCâncerInflamação
  19. 2021

    Use of cannabis in urological cancer patients: A review to evaluate risk for cancer development, therapeutic use, and symptom management

    InconclusivoMetanáliseCâncerCâncer — BexigaCâncer — Rim+1
  20. 2020

    Cannabinoids and Prostate Cancer: A Systematic Review of Animal Studies

    FavorávelMetanáliseCâncerCanabinoides Sintéticos WIN-x
  21. 2020

    JZL184, A Monoacylglycerol Lipase Inhibitor, Induces Bone Loss in a Multiple Myeloma Model of Immunocompetent Mice

    InconclusivoEstudo em AnimaisCâncerCâncer — MamaOsteoporoseMonoacilglicerol Lipase (MAGL)+1
  22. 2020

    Synthetic cannabinoids AM-251 and AM-1241 induce cell death in prostate cancer cells

    FavorávelEstudo LaboratorialCâncerCanabinoides Sintéticos AM-x
  23. 2020

    Treatment With Cannabinoids as a Promising Approach for Impairing Fibroblast Activation and Prostate Cancer Progression

    FavorávelEstudo LaboratorialCâncerCanabinoides Sintéticos WIN-x
  24. 2019

    Prevalence and predictors of cannabis use among men receiving androgen-deprivation therapy for advanced prostate cancer

    FavorávelEnsaio ClínicoCâncer
  25. 2019

    Systematic review of the potential role of cannabinoids as antiproliferative agents for urological cancers

  26. 2019

    The Relationship between Cannabis and Male Infertility, Sexual Health, and Neoplasm: a Systematic Review

    InconclusivoMetanáliseCâncerInfertilidade MasculinaLibido+3
  27. 2019

    Towards the use of non-psychoactive cannabinoids for prostate cancer

    FavorávelMetanáliseCâncer
  28. 2018

    Report of Objective Clinical Responses of Cancer Patients to Pharmaceutical-grade Synthetic Cannabidiol

  29. 2018

    α-Pinene Inhibits Human Prostate Cancer Growth in a Mouse Xenograft Model

    FavorávelEstudo em AnimaisCâncer
  30. 2016

    Geraniol Suppresses Prostate Cancer Growth Through Down-Regulation of E2F8

    FavorávelEstudo LaboratorialCâncer
  31. 2016

    Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas.

  32. 2016

    Simultaneous Activation Of Induced Heterodimerization Between CXCR4 Chemokine Receptor And Cannabinoid Receptor 2 (CB2) Reveal A Mechanism For Regulation Of Tumor Progression

  33. 2016

    The antitumor effects of geraniol: Modulation of cancer hallmark pathways

    FavorávelMetanáliseCâncerCâncer — MamaCâncer — Pulmão+3
  34. 2016

    β‐caryophyllene and β‐caryophyllene oxide—natural compounds of anticancer and analgesic properties.

    FavorávelMetanáliseDorCâncerInflamação+16
  35. 2015

    Proapoptotic effect of endocannabinoids in prostate cancer cells

    FavorávelEstudo LaboratorialCâncerAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+2
  36. 2014

    Advances in transient receptor potential vanilloid-2 channel expression and function in tumor growth and progression

  37. 2013

    Critical Appraisal Of The Potential Use Of Cannabinoids In Cancer Management

  38. 2013

    Non-THC Cannabinoids Inhibit Prostate Carcinoma Growth In Vitro And In Vivo: Pro-apoptotic Effects And Underlying Mechanisms

    FavorávelEstudo em AnimaisCâncerCanabigerol (CBG)Canabinol (CBN)+5
  39. 2012

    The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications

  40. 2011

    b-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation.

    FavorávelEstudo LaboratorialCâncerCâncer — Mama
  41. 2011

    Minireview: Recent Developments in the Physiology and Pathology of the Lysophosphatidylinositol-Sensitive Receptor GPR55

  42. 2009

    Increased Expressions Of Cannabinoid Receptor-1 And Transient Receptor Potential Vanilloid-1 In Human Prostate Carcinoma

    FavorávelEstudo LaboratorialCâncer
  43. 2008

    Management of bone metastases

    FavorávelMetanáliseDorCâncerCâncer — MamaTHC:CBD Farmacêutico+8
  44. 2006

    The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells

  45. 2005

    Cannabinoid Receptor As A Novel Target For The Treatment Of Prostate Cancer

    FavorávelEstudo LaboratorialCâncerCanabinoides Sintéticos WIN-xCanabinoides Sintéticos SR-x
  46. 2003

    Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production.

    FavorávelEstudo LaboratorialCâncerAnandamida (AEA)
  47. 2000

    Phase I pharmacokinetic trial of perillyl alcohol in patients with refractory solid malignancies

    InconclusivoEnsaio ClínicoCâncerCâncer — Mama
  48. 2000

    Suppression Of Nerve Growth Factor Trk Receptors And Prolactin Receptors By Endocannabinoids Leads To Inhibition Of Human Breast And Prostate Cancer Cell Proliferation

    FavorávelEstudo LaboratorialCâncerCâncer — MamaAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+2
  49. 1999

    Δ9-Tetrahydrocannabinol Induces Apoptosis In Human Prostate PC-3 Cells Via A Receptor-independent Mechanism

    FavorávelEstudo LaboratorialCâncerTetraidrocanabinol (THC)Canabinoides Sintéticos AM-x+1

Continue por aqui

Perguntas frequentes

Quantos estudos sobre câncer — próstata estão indexados no acervo?
São 49 estudos, publicados entre 1999 e 2024. O acervo inteiro tem 7.640 registros.
Que tipos de estudo predominam?
Metanálise: 26 · Estudo Laboratorial: 16 · Estudo em Animais: 4 · Ensaio Clínico: 3. A classificação segue o desenho declarado na fonte.
O que significa a classificação de resultado?
É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 40 favoráveis, 7 inconclusivos e 2 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. Câncer — Próstata — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/condicao/cancer-prostata/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). Câncer — Próstata — estudos científicos sobre cannabis. https://cannabisindica.com.br/condicao/cancer-prostata/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.